Therapy News and Research

RSS

Pathway preferential estrogens may be a safer alternative to hormone replacement therapy, study shows

Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure.

29 Oct 2021

Brown fat could be the key to healthy metabolism in obese people

Not all forms are obesity are the same and brown fat could make all the difference. A study led by Florian Kiefer's research group from the Division of Endocrinology and Metabolism of the Department of Medicine III at MedUni Vienna and Vienna General Hospital shows that people who are seriously overweight (obese) who also have active brown fat have a healthier metabolism and use more energy than obese people without brown fat.

29 Oct 2021

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical supervision.

29 Oct 2021

Beckman Coulter Life Sciences expands customer access to experts, resources with 3D Digital Campus

Building on a relentless commitment to customer service and innovation, Beckman Coulter Life Sciences debuts a powerful new interactive customer resource with the launch of its Digital Campus.

From Beckman Coulter Life Sciences - Flow Cytometry 29 Oct 2021

England could be the first to prescribe e-cigarettes to tackle disparities in smoking rates

E-cigarettes could be prescribed on the NHS in England to help people stop smoking tobacco products, as Health and Social Care Secretary Sajid Javid welcomed the latest step forward in the licensing process for manufacturers.

28 Oct 2021

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.

28 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

'Theta activity' in the brain found to be divergent for people with mental health conditions

A new review of current literature, conducted by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, has found that irregular responses in the brain to challenging tasks and mistakes could be key to understanding common links between abnormal behaviors in a range of mental illness and cognitive disorders.

28 Oct 2021

Study offers hope for a new therapeutic option for patients with severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.

28 Oct 2021

Malaria: An Interview with the World Health Organization

In this interview, we spoke to Dr. Akpaka Kalu, the World Health Organization's team leader for malaria in Africa, about the groundbreaking malaria vaccine rollout announcement.

28 Oct 2021

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics announced today that it has closed a $40 million (circa £30 million) investment round.

From Fluidic Sciences and Sphere Bio 28 Oct 2021

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.

28 Oct 2021

Survey: Young adults with chronic pain more likely to use cannabis or CBD oil to manage the condition

Young adults, ages 18-34, are more likely to report experiencing chronic pain compared to older adults (65% vs. 52% ages 35+), with a large majority of them (73%) saying they are in pain every day, according to a new survey conducted online by The Harris Poll on behalf of the Samueli Foundation.

27 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.

27 Oct 2021

Therapy News and Research

Pathway preferential estrogens may be a safer alternative to hormone replacement therapy, study shows

Brown fat could be the key to healthy metabolism in obese people

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Beckman Coulter Life Sciences expands customer access to experts, resources with 3D Digital Campus

England could be the first to prescribe e-cigarettes to tackle disparities in smoking rates

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

'Theta activity' in the brain found to be divergent for people with mental health conditions

Study offers hope for a new therapeutic option for patients with severe asthma

Malaria: An Interview with the World Health Organization

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

Survey: Young adults with chronic pain more likely to use cannabis or CBD oil to manage the condition

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Promising new therapy for mesothelioma to enter a Phase I clinical trial

Physical therapy associated with lower odds of long-term opioid use after total knee replacement

McMaster-Hamburg collaboration discovers promising new antimalarial compound

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News